| Value | ₹47.13 Cr |
|---|
NSE filing, NSE: REXPRO. Summary written from the filing by ALFA Finder's alert engine.
Rexpro Enterprises Ltd: key numbers
- Share price
- ₹28.80
- Market cap
- ₹32.27 Cr
- Revenue (annual)
- ₹73.69 Cr
- Net profit (annual)
- ₹2.02 Cr
- P/E (TTM)
- 16.0×Sector 33.4×
- Promoter holding
- 66.98%
- FII holding
- 4.33%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rexpro Enterprises Ltd
All →Rexpro Enterprises Other Announcement
Rexpro Enterprises filed the Acuité monitoring agency report for H1 FY2026-27 on IPO proceeds. The report flags delayed utilisation and an unused inorganic-growth object past its March 2026 timeline.
Rexpro Enterprises Management Change
Rexpro's Company Secretary and Compliance Officer, Abhishek Surendra Yadav, resigned effective October 30, 2026. The resignation cites personal reasons and no other material reasons.
Rexpro Enterprises Annual General Meeting
Rexpro Enterprises Limited conducted its 14th Annual General Meeting via video conferencing on September 30, 2026. Shareholders considered resolutions regarding financial statements, director reappointment, and related party transactions.
Rexpro Enterprises Annual General Meeting
Rexpro Enterprises Ltd. has announced its 14th AGM will be held on 30th September 2026. The company also fixed book closure dates and an e-voting cut-off.
Rexpro Enterprises Management Change
Rexpro Enterprises Limited appointed Mr. Abhishek Surendra Yadav as Company Secretary, succeeding Ms. Khushboo Nilesh Rawat, who resigned effective September 5, 2026.
Rexpro Enterprises Board Meeting Outcome
Rexpro Enterprises approved loans of ₹5 Crore each to two subsidiaries, totaling ₹10 Crore. It also announced the AGM date and changes to the Company Secretary.
- Value
- ₹10.00 Cr
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr